Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT03721120
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years;
* Patients with clinico-radiological suspicious presentation of stage IV lung cancer;
* No prior chemotherapy for locally advanced or metastatic NSCLC;
* Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 (Appendix 2);
* Life expectancy \> 12 weeks;
* No contraindication to systemic lung cancer treatment;
* Covered by a medical insurance;
* Signed informed consent prior to any study-specific procedure;
* No prior biopsy or cytology for lung cancer diagnosis.
Exclusion Criteria:
* Pregnant or breastfeeding women;
* Patient concurrently using other approved or investigational antineoplastic agents;
* Major concurrent disease affecting cardiovascular system, liver, kidneys, hematopoietic system or else considered as clinically important by the investigator and that could be incompatible with patient's participation in this trial or would likely interfere with study procedures or results;
* Prior history of malignancies other than study disease (except for basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix) unless the patient has been free of the disease for at least 3 years;
* Patient requiring tutorship or curatorship.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03721120
Study Brief:
Protocol Section:
NCT03721120